The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Changes in p16INK4a (p16) expression, a biomarker of aging, in peripheral blood T-cells (PBTC) in patients receiving anthracycline (A) vs non-anthracycline (NoA) chemotherapy (CRx) for early-stage breast cancer (EBC).
 
Shlomit Strulov Shachar
No Relationships to Disclose
 
Allison Mary Deal
No Relationships to Disclose
 
Natalia Mitin
Employment - HealthSpan
Stock and Other Ownership Interests - HealthSpan
Patents, Royalties, Other Intellectual Property - Healthspan
 
Kirsten A Nyrop
No Relationships to Disclose
 
Jordan T Lee
No Relationships to Disclose
 
Seul Ki Choi
No Relationships to Disclose
 
Will Pulley
No Relationships to Disclose
 
Emily Fox Bell
No Relationships to Disclose
 
Nora Christopher
No Relationships to Disclose
 
Grant Richard Williams
No Relationships to Disclose
 
Lisa A. Carey
Research Funding - Genentech/Roche (Inst); GlaxoSmithKline (Inst)
 
Carey K. Anders
Consulting or Advisory Role - Angiochem; Genentech/Roche; GERON; Kadmon; Lilly; Merrimack; Nektar; Novartis; Sanofi; to-BBB technologies BV
Research Funding - Angiochem (Inst); Cascadian Therapeutics (Inst); Geron (Inst); Lilly (Inst); Merck (Inst); Merrimack (Inst); Nektar (Inst); Novartis (Inst); Oncothyreon (Inst); Puma Biotechnology (Inst); Sanofi (Inst); Tesaro (Inst); to-BBB technologies BV (Inst)
Patents, Royalties, Other Intellectual Property - Jones and Bartlell; Up to Date.com
 
Trevor Augustus Jolly
No Relationships to Disclose
 
Elizabeth Claire Dees
Consulting or Advisory Role - Novartis (I)
Research Funding - Bayer; Cerulean Pharma; Genentech/Roche; Lilly; Merck; Novartis; Pfizer
 
Katherine Elizabeth Reeder-Hayes
No Relationships to Disclose
 
Hanna Kelly Sanoff
Research Funding - Bayer (Inst); Immunomedics (Inst); Merck (Inst); Novartis (Inst); Precision Biologics (Inst)
 
Norman E. Sharpless
Leadership - G1 Therapeutics; Healthspan
Stock and Other Ownership Interests - G1 Therapeutics; Healthspan
Honoraria - G1 Therapeutics; Pfizer
Consulting or Advisory Role - G1 Therapeutics; Healthspan
Research Funding - GlaxoSmithKline (Inst); Merck (Inst)
Patents, Royalties, Other Intellectual Property - Patent on chemoprotection licensed to G1 Therapeutics
Travel, Accommodations, Expenses - G1 Therapeutics; Pfizer; Unity Biotechnology
 
Hyman B. Muss
Consulting or Advisory Role - Pfizer
Research Funding - numerous at UNC (Inst)